Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 40, 2006, Pages 14935-14940

  Kelly, Gemma L ^a   Milner, Anne E ^a   Baldwin, Gouri S ^a   Bell, Andrew I ^a   Rickinson, Alan B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cell survival; Viral genome integration; Viral lymphomagenesis; Viral transformation

Indexed keywords

APOPTOSIS INHIBITOR; EPSTEIN BARR VIRUS ANTIGEN; MYC PROTEIN; VIRUS ENVELOPE PROTEIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE TRANSLOCATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; LYMPHOMA CELL LINE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS EXPRESSION; VIRUS GENOME; VIRUS LATENCY;

APOPTOSIS; BURKITT LYMPHOMA; CELL LINE, TUMOR; CHILD; CLONE CELLS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRUS LATENCY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 33749537262     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0509988103     Document Type: Article

References (38)

1. Kuppers R (2003) Nat Rev Immunol 3:801-812.
2. Rickinson AB, Kieff E (2001) in Fields Virology, eds Knipe DM, Howley PM (Lippincott, Philadelphia), Vol II, pp 2575-2627.
3. Kieff E, Rickinson A (2001) in Fields Virology, eds Knipe DM, Howley PM (Lippincott, Philadelphia), Vol II, pp 2511-2573.
4. Magrath I (1990) Adv Cancer Res 55:133-270.
5. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB (1987) EMBO J 6:2743-2751.
6. Kennedy G, Komano J, Sugden B (2003) Proc Natl Acad Sci USA 100:14269-14274.
7. Komano J, Sugiura M, Takada K (1998) J Virol 72:9150-9156.
8. Komano J, Maruo S, Kurozumi K, Oda T, Takada K (1999) J Virol 73:9827-9831.
9. Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT (2000) J Virol 74:10223-10228.
10. Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT (1999) Mol Cell Biol 19:1651-1660.
11. Polack A, Hortnagel K, Pajic A, Christoph B, Baier B, Falk M, Mautner J, Geltinger C, Bornkamm GW, Kempkes B (1996) Proc Natl Acad Sci USA 93:10411-10416.
12. Pajic A, Staege MS, Dudziak D, Schuhmacher M, Spitkovsky D, Eissner G, Brielmeier M, Polack A, Bornkamm GW (2001) Int J Cancer 93:810-816.
13. Kelly G, Bell A, Rickinson A (2002) Nat Med 8:1098-1104.
14. Kelly GL, Milner AE, Tierney RJ, Croom-Carter DS, Altmann M, Hammerschmidt W, Bell AI, Rickinson AB (2005) J Virol 79:10709-10717.
15. Shannon-Lowe C, Baldwin G, Feederle R, Bell A, Rickinson A, Delecluse HJ (2005) J Gen Virol 86:3009-3019.
16. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB (1991) Nature 349:612-614.
17. Pelengaris S, Khan M, Evan G (2002) Nat Rev Cancer 2:764-776.
18. Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K (1994) J Virol 68:6069-6073.
19. Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wright DH, Young LS (1995) Blood 86:659-665.
20. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K (2002) EMBO J 21:954-965.
21. Abbot SD, Rowe M, Cadwallader K, Ricksten A, Gordon J, Wang F, Rymo L, Rickinson AB (1990) J Virol 64:2126-2134.
22. Wang F, Tsang SF, Kurilla MG, Cohen JI, Kieff E (1990) J Virol 64:3407-3416.
23. Zimber-Strobl U, Suentzenich KO, Laux G, Eick D, Cordier M, Calender A, Billaud M, Lenoir GM, Bornkamm GW (1991) J Virol 65:415-423.
24. Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm GW, Kempkes B (1996) EMBO J 15:375-382.
25. Lee JM, Lee KH, Weidner M, Osborne BA, Hayward SD (2002) Proc Natl Acad Sci USA 99:11878-11883.
26. Lee JM, Lee KH, Farrell CJ, Ling PD, Kempkes B, Park JH, Hayward SD (2004) J Virol 78:12694-12697.
27. Johannsen E, Miller CL, Grossman SR, Kieff E (1996) J Virol 70:4179-4183.
28. Waltzer L, Perricaudet M, Sergeant A, Manet E (1996) J Virol 70:5909-5915.
29. Babcock GJ, Hochberg D, Thorley-Lawson AD (2000) Immunity 13:497-506.
30. Kurth J, Hansmann ML, Rajewsky K, Kuppers R (2003) Proc Natl Acad Sci USA 100:4730-4735.
31. Gallagher A, Armstrong AA, MacKenzie J, Shield L, Khan G, Lake A, Proctor S, Taylor P, Clements GB, Jarrett RF (1999) Int J Cancer 84:442-448.
32. Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J (2001) J Clin Oncol 19:420-424.
33. Junying J, Herrmann K, Davies G, Lissauer D, Bell A, Timms J, Reynolds GM, Hubscher SG, Young LS, Niedobitek G, Murray PG (2003) Virology 306:236-243.
34. Yao QY, Tierney RJ, Croom-Carter D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB (1996) J Virol 70:4895-4903.
35. Delecluse HJ, Schuller S, Hammerschmidt W (1993) EMBO J 12:3277-3286.
36. Polack A, Hartl G, Zimber U, Freese UK, Laux G, Takaki K, Hohn B, Gissmann L, Bornkamm GW (1984) Gene 27:279-288.
37. Milner AE, Palmer DH, Hodgkin EA, Eliopoulos AG, Knox PG, Poole CJ, Kerr DJ, Young LS (2002) Cell Death Differ 9:287-300.
38. Schuurhuis GJ, Oberink JW, Brontje PM, Broxterman HJ (1997) Exp Hematol 25:754.